DLD Asset Management’s Zymeworks ZYME Stock Holding History

DLD Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,000	Closed	-$436K	–	476
2025 Q3	$342K	Buy	+20,000	New	+$286K	0.02%	239

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DLD Asset Management's ZYME Position: Q4 2025 in Review

DLD Asset Management sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 20,000 shares — an estimated $436K sold.

DLD Asset Management first reported a position in ZYME in Q3 2025 and held it in 1 quarter. The position peaked at $342K in Q3 2025. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.

DLD Asset Management reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
DLD Asset Management sold 20,000 Zymeworks shares in Q4 2025, an estimated $436K.
DLD Asset Management first reported a position in Zymeworks in Q3 2025 and held it in 1 quarter.
DLD Asset Management's Zymeworks position peaked at $342K in Q3 2025.
209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.

Based on DLD Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.